CN110075196A - Myogenic 1 - Google Patents
Myogenic 1 Download PDFInfo
- Publication number
- CN110075196A CN110075196A CN201810105323.5A CN201810105323A CN110075196A CN 110075196 A CN110075196 A CN 110075196A CN 201810105323 A CN201810105323 A CN 201810105323A CN 110075196 A CN110075196 A CN 110075196A
- Authority
- CN
- China
- Prior art keywords
- wound
- myogenic
- drug
- pain
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Myogenic 1.Technical field: the present invention is practically applicable to the external drug of integumentary musculature tissue damage caused by a variety of causes.Background technique: though currently known external drug, which plays the role of anti-inflammatory, promotes wound healing, but bacterium cannot be prevented to invade from wound, cause infection, do not promote injected organism tissue cell fast-growth and because of pain caused by wound, it is slowly improved with pain, required cost to cicatrize a wound.Summary of the invention: in order to overcome the shortcomings of existing drug, the present invention, which provides a kind of drug " myogenic I ", can solve above-mentioned deficiency.Present invention solves the technical problem that: be that wound is made quickly to form a scab first, keep drying because prevent bacterial invasion, prevent from infecting, institute so as not to wrapping.Promote cell fast-growth, mitigates patient pain and achieve the purpose that shorten the course of disease, reduce expense.The present invention is suitable for: after wound caused by a variety of causes, such as weapons, operation, scald, ulcer do not close up long, sore of shaking.
Description
Fields: the present invention relates to a kind of external drugs for treating various wounds, specifically using Chinese medicine as raw material
The Chinese medicine powder of preparation, the present invention and is related to the preparation method of the drug.
The prior art:
There are many reason of causing wound, have knife wound, wound, scratch, the routed rear, bedsore of ulcer etc., are just not easy to heal.~it is to control
It is more to treat time long cost；Second is that missing the good opportunity of early recovery.Dominant mechanism is wound without extremely early healing, bacterium be easy from
Wound enters in vivo, causes infection, or even cannot heal for a long time, causes septicemia etc..
The " closed " that is critical to of wound prevents bacterium from entering from wound, and prevention infection is secondary to make defect skin histology fast
Fast-growing is long, makes wound healing, and wound patient is generally existing to eat anti-inflammatory drug daily, daily infusion 1-2 times, with general sterilizing
Crystal powder etc., and effect is undesirable, does is good slowly, why this? it is not treated from key and at all mainly, myogenic 1
Does is it to solve from key and fundamentally this problem, where is its secret? its secret is that wound quick-make, knot can be made
Scab makes body tissue fast-growth.For different wounds can play myogenic hemostasis, promoting blood circulation and stopping pain, heat-clearing hygroscopic, sore it
Effect makes wound healing acceleration.
Goal of the invention:
The present invention not only can quickly heal to various wounds, but also the symptom that wound occurs can be mitigated or be disappeared.Such as subtract
The pain of light patient has the secretion for restraining it to apparent wound is oozed out, and wound is made to keep drying, and the present invention provides the drug
Preparation method, the invention discloses a kind of new drug treated wound, it use first-class pure natural Chinese herbal medicine resin,
Chinese medicine is milled to powder with medicinal herb grinder under conditions of bacteria-and dust-free by the selected removing impurity such as minerals, shell
Shape, blending mixes according to the ratio, and the Chinese medicine mixed powder external application is easy to use.Significant in efficacy, the course of disease shortens.
Myogenic 1 is formed by 7 kinds of purification of tcm, wound caused by primary treatment a variety of causes, such as knife wound, bullet wound, water
Burning hot wound, ulcer do not close up long, the patients such as bedsore.
The content of invention:
The treatment of wound is not just required to recover quickly, but also to mitigate the pain of patient, myogenic 1 is through to various
The symptom that wound caused by reason occurs is made wound quickly form a scab, is made by myogenic hemostasis, heat clearing and blood circulation promoting analgesic, hygroscopic sore
The body tissue fast-growth of missing, makes wound healing, mitigates the pain of patient.Myogenic 1 is the various wound poles for the treatment of
For rare good medicine.After patient uses myogenic 1, effective active enters body in drug, reduces the secretion of mucosal tissue, human body
Temperature and drug property, keep wound dry, form a scab, play a protective role in a relatively short period of time, prevent the thin of outside
Bacterium enters internal from wound, it is therefore prevented that wound infection.Body tissue fast-growth is stimulated, and achievees the purpose that rehabilitation.Myogenic 1
It is to start with from the essence of wound, plays prevention infection, promotes the multi-efficiencies such as body tissue growth.
Myogenic 1 has the following characteristics that
1, myogenic: make body tissue fast-growth.
2, stop blooding: having hemostasia effect to bleeding caused by open wound.
3, clearing away heat to and alleviating pain: there is the effect of anti-inflammatory, analgesic to inflammation caused by various wounds and pain.
4, invigorate blood circulation: what the growth of body tissue be unable to do without blood is blood retardance for, the wound to long-term disunion, makes to hurt
Mouth does not recover for a long time.
5, hygroscopic sore: to the people more than the tissue secretion objects of the appearance such as wet sore, scald, body mucosal secretions is can be reduced and reached
The effect of sending out sore wet.
Invention effect
It is compared with conventional externally applied drug, the unique distinction that myogenic 1 shows the following aspects:
It 1, is to be developed for the symptom conversion that the various state of an illness occur, through starting with to different pathogenies with numerous drugs
Wound is recuperated under medical treatment comprehensively, from myogenic hemostasis, clearing away heat to and alleviating pain, promoting blood circulation, hygroscopic sore, and treats and hurts caused by various diseases.
2, by preventing extraneous bacterium from immersing, pass through anti-inflammatory, prevention infection.
3, in line with wound circumference tissue fast-growth is promoted, make wound healing, shorten the course of disease.
4, in line with externally applied drug Small side effects, while local absorption is rapid, the symptom occurred from the course of disease can be treated, thus
The pain for mitigating patient, finally reaches the purpose of rehabilitation.
The cause of disease of wound is more, and using symptom as guiding principle, the symptom that different syndromes occur establishes corresponding therapeutic rules, whole
It is a treat wound during must be from myogenic, hemostasis, clearing away heat to and alleviating pain, promoting blood circulation, hygroscopic sore, this is the effective way treated wound
Diameter, in drug of comforming, each medicine reaches respective effect in vivo, depends merely on certain drug therapy, and effect is undesirable, and medication is as used
Soldier, it is necessary to start with from the overall process of the course of disease, prevent the generation of complication, to treat, the optimal treatment for the treatment of both manifestation and root cause of disease at all
Boundary.
According to the pathology of wound, which makes to draw a variety of causes based on injected organism tissue fast-growth to prevent bacterial invasion
Rise wound can complete treatment, accomplish myogenic hemostasis, clearing away heat to and alleviating pain, promoting blood circulation, the comprehensive composite treatment of hygroscopic sore.
Prescription and side's justice analysis:
Calcined gypsum: clearing heat-fire restrains myogenic
Dragon's blood: hemostasis, myogenic, sore
Calcined Dragon's bone: hygroscopic, myogenic
Olibanum, myrrh: promoting blood circulation and stopping pain, myogenic
Cuttle bone: astringing to arrest bleeding, hygroscopic sore
Borneol: clearing away heat to and alleviating pain
1, the calcined gypsum in myogenic drug, dragon's blood, calcined Dragon's bone, olibanum, myrrh can myogenic, calcined gypsum also can be reduced mucous membrane
Secretion.
2, clearing away heat to and alleviating pain: borneol energy heat-clearing in drug, and can antibacterial anti-inflammatory.Borneol, olibanum, myrrh have the function of analgesic.
3, invigorate blood circulation, stop blooding: olibanum, myrrh are invigorated blood circulation, and dragon's blood, cuttle bone have hemostasia effect in drug.
4, hygroscopic sore: calcined Dragon's bone, cuttle bone have the effect of hygroscopic sore.
Claims (3)
1. a kind of Chinese medicine powder for treating various wounds, it is characterized in that: formula composition, calcined gypsum, dragon's blood, calcined Dragon's bone, cuttle bone,
Olibanum, myrrh, borneol.
2. a kind of Chinese medicine powder for treating various wounds according to claim 1, it is characterized in that: being forged by weight ingredient
2 parts of gypsum, each 1 part of dragon's blood, calcined Dragon's bone, cuttle bone, olibanum adds myrrh to close 1 part, 1/10 part of borneol medicine-feeding synthesis weight.
3. above-mentioned Chinese medicine is ground into micro mist, each medicine by a kind of Chinese medicine powder for treating various wounds according to claim 1
Material stirs evenly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810105323.5A CN110075196A (en) | 2018-01-26 | 2018-01-26 | Myogenic 1 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810105323.5A CN110075196A (en) | 2018-01-26 | 2018-01-26 | Myogenic 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110075196A true CN110075196A (en) | 2019-08-02 |
Family
ID=67412722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810105323.5A Withdrawn CN110075196A (en) | 2018-01-26 | 2018-01-26 | Myogenic 1 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110075196A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110448516A (en) * | 2019-09-27 | 2019-11-15 | 徐新鹏 | A kind of Chinese materia medica preparation composition brightening smoothing wrinkle |
-
2018
- 2018-01-26 CN CN201810105323.5A patent/CN110075196A/en not_active Withdrawn
Non-Patent Citations (2)
| Title |
|---|
| 于慧敏等: "外伤 I号治疗慢性皮肤溃疡30例", 《河北中医》 * |
| 王海等: "生肌散治疗伤口经久不愈的临床应用研究", 《辽宁中医药大学学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110448516A (en) * | 2019-09-27 | 2019-11-15 | 徐新鹏 | A kind of Chinese materia medica preparation composition brightening smoothing wrinkle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101933959B (en) | Medicament for treating canker and preparation method thereof | |
| CN101204529A (en) | Medicine for wound-curing and scar-dispeling | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN103893557A (en) | Traditional Chinese medicine preparation for treating bedsore | |
| CN102716281B (en) | Care solution for cleaning wounds after operation | |
| CN102274355B (en) | Externally applied medicament for treating foot-and-mouth disease in pigs | |
| CN110075196A (en) | Myogenic 1 | |
| CN110075258A (en) | A kind of diabetic foot ulcer externally applied drug | |
| CN104147524A (en) | Traditional Chinese medicine preparation for treating peptic ulcer | |
| CN107397886A (en) | Chinese medicine composition for preventing and treating piglet red dysentery and its preparation method and application | |
| CN112891437A (en) | Traditional Chinese medicine composition for treating gastric ulcer and preparation method thereof | |
| CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
| CN101810668A (en) | Toxin drawing plaster | |
| CN106389620B (en) | It is a kind of for treating the Washout traditional Chinese medicine composition of perianal eczema | |
| CN104208552B (en) | One kind treats tetanic Chinese medicine preparation | |
| CN111166771A (en) | Traditional Chinese medicine composition for promoting tissue regeneration and skin growth of wounds and preparation method and application thereof | |
| CN100355437C (en) | Medicine for treating scald and burn and preparing method | |
| CN104083630A (en) | Traditional Chinese medicine ointment for treating bedsore and preparation method thereof | |
| CN105168448B (en) | A kind of compound burn cream and preparation method thereof | |
| CN104984088A (en) | Traditional Chinese medicine prescription for treating trauma infection | |
| CN105477214A (en) | Spray for treating scapulohumeral periarthritis and preparation method thereof | |
| CN107714781B (en) | Pharmaceutical composition for treating burns and scalds and preparation method and application thereof | |
| CN106109854A (en) | A kind of pharmaceutical composition promoting skin wound healing | |
| CN104689016A (en) | Externally applied traditional Chinese medicine for treating burns | |
| Usmonovna | PHARMACOTHERAPEUTIC PROPERTIES OF DRUGS USED IN THE TREATMENT OF GASTRIC ULCER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190802 |
|
| WW01 | Invention patent application withdrawn after publication |